» Articles » PMID: 12975454

IL-1 Plays an Important Role in Lipid Metabolism by Regulating Insulin Levels Under Physiological Conditions

Overview
Journal J Exp Med
Date 2003 Sep 17
PMID 12975454
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

IL-1 is a proinflammatory cytokine that plays important roles in inflammation. However, the role of this cytokine under physiological conditions is not known completely. In this paper, we analyzed the role of IL-1 in maintaining body weight because IL-1 receptor antagonist-deficient (IL-1Ra-/-) mice, in which excess IL-1 signaling may be induced, show a lean phenotype. Body fat accumulation was impaired in IL-1Ra-/- mice, but feeding behavior, expression of hypothalamic factors involved in feeding control, energy expenditure, and heat production were normal. When IL-1Ra-/- mice were treated with monosodium glutamate (MSG), which causes obesity in wild-type mice by ablating cells in the hypothalamic arcuate nucleus, they were resistant to obesity, indicating that excess IL-1 signaling antagonizes the effect of MSG-sensitive neuron deficiency. IL-1Ra-/- mice showed decreased weight gain when they were fed the same amount of food as wild-type mice, and lipid accumulation remained impaired even when they were fed a high-fat diet. Interestingly, serum insulin levels and lipase activity were low in IL-1Ra-/- mice, and the insulin levels were low in contrast to wild-type mice after MSG treatment. These observations suggest that IL-1 plays an important role in lipid metabolism by regulating insulin levels and lipase activity under physiological conditions.

Citing Articles

Systematic Review of , , , , , and Gene Polymorphisms and Meta-Analysis of Variant and Its Association with Overweight and Obesity Risk in Men.

Bojarczuk A, Garbacz A, Zekanowski C, Borzemska B, Cieszczyk P, Maculewicz E Int J Mol Sci. 2025; 25(24.

PMID: 39769263 PMC: 11679641. DOI: 10.3390/ijms252413501.


Maternal characteristics are associated with human milk anti-inflammatory proteins in two populations.

Miller E Sci Rep. 2024; 14(1):30941.

PMID: 39730549 PMC: 11681199. DOI: 10.1038/s41598-024-81806-z.


Pattern-Recognition Receptors and Immunometabolic Reprogramming: What We Know and What to Explore.

Kumar V, Stewart Iv J J Innate Immun. 2024; 16(1):295-323.

PMID: 38740018 PMC: 11250681. DOI: 10.1159/000539278.


The immunometabolic function of VGLL3 and female-biased autoimmunity.

Kennicott K, Liang Y Immunometabolism (Cobham). 2024; 6(2):e00041.

PMID: 38726338 PMC: 11078290. DOI: 10.1097/IN9.0000000000000041.


Determinants of serum cytokines in a population sample of healthy subjects from Iran.

Mirhafez S, Zarifian A, Movahedi A, Ferns G, Sathyapalan T, Ghayour-Mobarhan M Arch Med Sci Atheroscler Dis. 2023; 8:e89-e95.

PMID: 38089159 PMC: 10711785. DOI: 10.5114/amsad/171708.


References
1.
Dinarello C . Biologic basis for interleukin-1 in disease. Blood. 1996; 87(6):2095-147. View

2.
Memon R, Feingold K, MOSER A, Fuller J, Grunfeld C . Regulation of fatty acid transport protein and fatty acid translocase mRNA levels by endotoxin and cytokines. Am J Physiol. 1998; 274(2):E210-7. DOI: 10.1152/ajpendo.1998.274.2.E210. View

3.
Tran P, Gleason C, Poitout V, Robertson R . Prostaglandin E(2) mediates inhibition of insulin secretion by interleukin-1beta. J Biol Chem. 1999; 274(44):31245-8. DOI: 10.1074/jbc.274.44.31245. View

4.
Horai R, Saijo S, Tanioka H, Nakae S, Sudo K, Okahara A . Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med. 2000; 191(2):313-20. PMC: 2195765. DOI: 10.1084/jem.191.2.313. View

5.
Schwartz M, Woods S, Porte Jr D, Seeley R, Baskin D . Central nervous system control of food intake. Nature. 2000; 404(6778):661-71. DOI: 10.1038/35007534. View